Clinical

Dr. Peter Marks, the former top FDA vaccine official who abruptly resigned from the regulator earlier this year, has joined …

Partnership will analyse m6A RNA modifications in patient samples to support development of STC‑15 STORM Therapeutics has entered a new …

Immunology is one of pharma’s greatest not-so-secret weapons, driving breakthroughs across the spectrum from cancer to infectious disease to the …

Arthrosi’s investigational gout treatment is currently being evaluated in global studies Sobi has entered into an agreement to acquire Arthrosi …

By: Michael Gibney • Published June 6, 2025 Antibody-drug conjugates were the topic du jour at this year’s annual meeting …

Topadur has appointed Matthias Schäfer as CEO Topadur Pharma, a clinical-stage biotechnology company specialising in therapies for vascular regeneration, has …

When CEO Ben Lamm steps into the spotlight, it’s usually to talk about his efforts bringing extinct animals back to …

MRM’s platform could optimise the link between the gut microbiome and cancer outcomes MRM Health, a clinical-stage biopharmaceutical company developing …

The Huntington’s disease community celebrated a much-needed win last month when results for a gene therapy demonstrated slowed disease progression …

New consultancy aims to deliver personalised senior expertise in healthcare communications Miranda Dini has announced the launch of GOLD Strategy …